Glycan-Receptor Binding of the Novel Influenza A Virus H7N9 Hemagglutinin
Invention type: Technology
/
Case number: #16359
The present invention provides, among other things, systems (e.g., comprising compositions and/or methods) for diagnosis, prophylaxis, treatment, prevention, and/or characterization of influenza transmission and/or infection. The present invention also provides methods for monitoring influenza variants for their potential to present a pandemic risk to humans.
Researchers
Akila Jayaraman
/
Kannan Tharakaraman
/
Nathan Stebbins
/
Rahul Raman
/
Ram Sasisekharan
Departments: Department of Biological Engineering, School of Engineering
Technology Areas: Diagnostics: Assays / Therapeutics: Nucleic Acids, Proteins & Antibodies
Impact Areas: Healthy Living
-
human adaptation of h7 ha
United States of America | Granted | 10,526,375
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.